Star Equity Holdings Stock Today
| STRR Stock | USD 2.29 0.02 0.88% |
Performance0 of 100
| Odds Of DistressLess than 50
|
Star Equity is selling at 2.29 as of the 18th of January 2025; that is 0.88 percent increase since the beginning of the trading day. The stock's lowest day price was 2.27. Star Equity has 50 percent odds of going through some form of financial distress in the next two years and has generated negative returns to investors over the last 90 days. The performance scores are derived for the period starting the 19th of December 2024 and ending today, the 18th of January 2025. Click here to learn more.
Business Domain Pharmaceuticals, Biotechnology & Life Sciences | IPO Date 10th of June 2004 | Category Healthcare | Classification Health Care |
Star Equity Holdings, Inc. provides healthcare solutions in the United States and internationally. Star Equity Holdings, Inc. was founded in 1985 and is headquartered in Old Greenwich, Connecticut. Star Equity operates under Diagnostics Research classification in the United States and is traded on NASDAQ Exchange. The company has 3.22 M outstanding shares of which 26.14 K shares are at this time shorted by private and institutional investors with about 3.25 trading days to cover. More on Star Equity Holdings
Moving together with Star Stock
Moving against Star Stock
Follow Valuation Profit Patterns Daily Balance Of Power
Check how we calculate scores
Star Stock Highlights
ESG Sustainability
Environmental | Governance | Social |
| President Inc | Thatcher Butcher | |||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Business Concentration | Biotechnology, Pharmaceuticals, Biotechnology & Life Sciences, Health Care, NASDAQ Composite, NASDAQ Health Care, Health Care, Biotechnology, Diagnostics & Research, Healthcare (View all Sectors) | |||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Average Analyst Recommendation | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Financial Strength
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Debt LevelsStar Equity can leverage the use of borrowed funds to amplify returns from an investment. In general, analyzing the relationship between debt to total assets helps investors to understand Star Equity's financial leverage. It provides some insight into what part of Star Equity's total assets is financed by creditors.
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Star Equity Holdings (STRR) is traded on NASDAQ Exchange in USA. It is located in 53 Forest Avenue, Old Greenwich, CT, United States, 06870 and employs 171 people. Star Equity is listed under Biotechnology category by Fama And French industry classification. The company currently falls under 'Nano-Cap' category with a current market capitalization of 7.37 M. Star Equity Holdings conducts business under Biotechnology sector and is part of Health Care industry. The entity has 3.22 M outstanding shares of which 26.14 K shares are at this time shorted by private and institutional investors with about 3.25 trading days to cover.
Star Equity Holdings currently holds about 16.21 M in cash with 2.7 M of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 1.08.
Check Star Equity Probability Of Bankruptcy
Ownership AllocationStar Equity Holdings maintains significant amount of outstanding shares owned by insiders. An insider is usually defined as a CEO, other corporate executive, director, or institutional investor who own at least 10% of the company's outstanding shares.
Check Star Ownership Details
Star Stock Institutional Holders
| Instituion | Recorded On | Shares | |
| Susquehanna International Group, Llp | 2024-06-30 | 0.0 | |
| Wells Fargo & Co | 2024-09-30 | 0.0 | |
| Northern Trust Corp | 2024-06-30 | 0.0 | |
| Jpmorgan Chase & Co | 2024-09-30 | 0.0 | |
| Gradient Investments | 2024-06-30 | 0.0 | |
| Two Sigma Investments Llc | 2024-06-30 | 0.0 | |
| Vanguard Group Inc | 2024-09-30 | 35.9 K | |
| Geode Capital Management, Llc | 2024-09-30 | 15.6 K | |
| Renaissance Technologies Corp | 2024-09-30 | 12.7 K | |
| Bridgeway Capital Management, Llc | 2024-09-30 | 10.7 K | |
| Ubs Group Ag | 2024-09-30 | 2.4 K |
Star Equity Historical Income Statement
Star Stock Against Markets
Star Equity Corporate Management
| Jeffrey Eberwein | Executive Board | Profile | |
| Bob Halbert | Director Resource | Profile | |
| Martin Shirley | Pres Solutions | Profile | |
| Matthew Molchan | I Health | Profile | |
| CCP CEBS | Senior Resource | Profile | |
| Hannah Bible | Chief Officer | Profile | |
| Scott Jarchow | I EdgeBuilder | Profile |
Additional Tools for Star Stock Analysis
When running Star Equity's price analysis, check to measure Star Equity's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Star Equity is operating at the current time. Most of Star Equity's value examination focuses on studying past and present price action to predict the probability of Star Equity's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Star Equity's price. Additionally, you may evaluate how the addition of Star Equity to your portfolios can decrease your overall portfolio volatility.